Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas?

Expert Review of Anticancer Therapy
Rafael CaparicaEvandro de Azambuja

Abstract

Metronomic chemotherapy exerts its effects via inhibition of angiogenesis, immune modulation of the tumoral stroma, induction of senescence and apoptosis of tumor cells. Due to its favorable toxicity profile and its oral administration, metronomic chemotherapy arises as a promising alternative to be combined with endocrine therapy for the treatment of patients with luminal breast cancer. The present manuscript reviews the rationale supporting the combination of metronomic chemotherapy and endocrine therapy, discussing the studies that evaluated this regimen in the treatment of early-stage and metastatic breast cancer patients. Finally, we conclude by providing an expert opinion on the current role and perspectives for the combination of metronomic chemotherapy and endocrine therapy in the management of patients with luminal breast cancer. Retrospective series and early-phase clinical trials have shown promising signs of activity and a favorable toxicity profile with this regimen, which warrants further investigation as a treatment option for luminal breast cancer patients.

References

Mar 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P H WillemseH van Veelen
Jan 1, 1983·Breast Cancer Research and Treatment·W Mattsson
May 23, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hirotoshi UtsunomiyaKennichi Kakudo
Oct 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Guido BocciRobert S Kerbel
Jun 24, 2004·Toxicologic Pathology·Russell C Cattley, Robert R Radinsky
Dec 3, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ColleoniA Goldhirsch
Dec 8, 2005·Cancer Chemotherapy and Pharmacology·Jan-Erik DamberKlas Norrby
Aug 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto BottiniAlfredo Berruti
Feb 12, 2008·Breast Cancer Research and Treatment·J Michael DixonWilliam R Miller
Mar 29, 2008·Cancer Immunology, Immunotherapy : CII·Cédric MénardFrançois Ghiringhelli
Jan 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·KangAe LeeGregg L Semenza
Jan 8, 2010·Breast Cancer Research and Treatment·Mara A BonelliPier Giorgio Petronini
Sep 8, 2011·Journal of Cellular and Molecular Medicine·Yi WangXizhong Shen
Jun 19, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chih-Hao SuWei-Ping Lee
Dec 12, 2012·Clinical Breast Cancer·Rowan T Chlebowski
Jul 25, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K LienU Emmenegger
Jul 25, 2013·Nature Reviews. Clinical Oncology·Michail Ignatiadis, Christos Sotiriou
May 23, 2015·Stem Cells International·Marina Marçola, Camila Eleuterio Rodrigues
Oct 6, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Abhishek ShankarManmohan K Mahajan
Feb 10, 2016·Breast Cancer Research : BCR·Richard S FinnDennis J Slamon
May 25, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hope S RugoHarold J Burstein
Nov 26, 2016·Nature Reviews. Cancer·Jason S CarrollWayne D Tilley
Jun 16, 2017·The Breast : Official Journal of the European Society of Mastology·R CostaW J Gradishar
Mar 22, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hope S RugoAntoinette R Tan
May 3, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G N HortobagyiJ O'Shaughnessy
Jul 23, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoE P Winer
Jul 25, 2018·Therapeutic Advances in Medical Oncology·Sonia PernasShom Goel
Oct 23, 2018·The New England Journal of Medicine·Nicholas C TurnerMassimo Cristofanilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
P Khosravi Shahi, G Pérez Manga
© 2022 Meta ULC. All rights reserved